Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

MediWound (MDWD) EBIT Margin (2016 - 2025)

MediWound has reported EBIT Margin over the past 12 years, most recently at 417.78% for Q4 2025.

  • For Q4 2025, EBIT Margin fell 31331.0% year-over-year to 417.78%; the TTM value through Dec 2025 reached 167.05%, down 6310.0%, while the annual FY2025 figure was 148.98%, 5305.0% down from the prior year.
  • EBIT Margin for Q4 2025 was 417.78% at MediWound, down from 120.19% in the prior quarter.
  • Over five years, EBIT Margin peaked at 18.27% in Q4 2022 and troughed at 417.78% in Q4 2025.
  • A 5-year average of 108.41% and a median of 100.12% in 2021 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: surged 8244bps in 2022 and later plummeted -31331bps in 2025.
  • Year by year, EBIT Margin stood at 64.17% in 2021, then soared by 128bps to 18.27% in 2022, then plummeted by -499bps to 72.95% in 2023, then crashed by -43bps to 104.47% in 2024, then plummeted by -300bps to 417.78% in 2025.
  • Business Quant data shows EBIT Margin for MDWD at 417.78% in Q4 2025, 120.19% in Q3 2025, and 147.55% in Q2 2025.